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The global cancer burden is projected to increase by 50% by 2030 
and, disturbingly, most of the increase will occur in low- and middle-
income countries.[1-4] Unique features of cancer in Africa are the 
disproportionately high burden of cancers in women (56%), the high 
proportion of infection-related cancers (30% of all cancers), and the 
late stage at which cancer is diagnosed (e.g. 46% of breast cancer in 
South Africa (SA) is diagnosed at an advanced stage).[3-7] Cancer stage 
is a measure of cancer growth and spread, with stage at presentation 
being an important prognostic factor. Earlier stage at presentation, 
enabling more opportunities for curative treatment and improved 
outcomes, is therefore an important goal in any comprehensive 
cancer care policy.
Despite the growing burden, cancer has received relatively low 
public health priority in sub-Saharan Africa (SSA). The tide is 
turning in SA. In 2013, the first Ministerial Advisory Committee on 
the Prevention and Control of Cancer was established. In 2018, the 
SA President announced the set-up of a National Cancer Campaign. 
The National Department of Health has identified breast and cervical 
cancer as priority diseases. In SA, breast cancer is the most commonly 
diagnosed cancer among women and cervical cancer is the leading 
cause of cancer death among women.[8,9] In 2017, a new national 
breast cancer prevention and control policy was launched and the 
cervical cancer prevention policy was updated.[10,11] Both policies aim 
to reduce incidence and mortality rates and improve the quality of 
life of women in SA.
Despite screening programmes in high-income countries, the 
majority of cancers (85 - 90%) are diagnosed on the basis of symptomatic 
presentation.[12] Studies have shown that for symptom atic breast cancer 
a shorter time between the recognition of symptoms by women and 
the first medical consultation is associated with early-stage disease[13,14] 
and better breast cancer survival.[15,16] Further, a substantial proportion 
of advanced-stage breast cancer cases could be avoided if patients 
present within 1 month of detecting symptoms.[14] SA does not have a 
national public sector mammography screening programme. Typically, 
women with breast symptoms self-present to primary healthcare 
facilities and are referred to secondary- or tertiary-level facilities if 
further diagnostic work-up and treatment are required. Minimising 
the interval between first recognition of symptoms by women and the 
time of breast cancer diagnosis is dependent on timely presentation to 
primary healthcare providers by women with symptoms suggestive of 
breast cancer, appropriate assessment at the primary healthcare level, 
and good access to referral and treatment centres.
SA has had a national cervical cancer screening programme since 
2001. However, population screening coverage remains suboptimal 
(current national coverage 57% with marked provincial variation). [17] 
Many women diagnosed with cervical cancer still present with late-
stage symptomatic disease (personal communication, Dr L van Wijk, 
Department of Radiation Oncology, Groote Schuur Hospital, Cape 
Town, 23 May 2018). Consequently, understanding processes related to 
cancer symptom awareness and behaviours is important in developing 
interventions to promote timely presentation of cervical cancer.
 For both breast and cervical cancer there are subtle but important 
symptoms in early-stage disease, yet women often misinterpret these 
or wait until symptoms progress before they seek medical attention. 
Research has shown that cancer symptom awareness among the 
general population is low and that interventions to increase awareness 
lead to better outcomes.[18-20] A study in Malaysia demonstrated that 
a public cancer awareness programme coupled with staff training 
reduced late-stage presentation of breast and cervical cancer by half 
over a 4-year period.[19]
For people with potential symptoms of cancer, the journey to 
cancer diagnosis is complex and influenced by a multitude of factors 
including knowledge and awareness of cancer symptoms, symptom 
experiences, risk perception, and psychological, sociocultural and 
health system barriers to healthcare.[21-31] The Model of Pathways 
to Treatment provides a useful research framework to understand 
patient journeys, as it takes into account the complicated and dynamic 
nature of help-seeking behaviour.[32,33] By increasing understanding of 
the factors influencing the key events in the pathway to care, the 
model can be used to identify targets for interventions in order to 
encourage early detection, presentation and treatment. An important 
first research step is the development of culturally relevant and locally 
validated questionnaires to accurately measure symptom awareness 
and help-seeking behaviour in SA. A project being conducted in SA 
and Uganda and supported by the South African Medical Research 
Council, the Cancer Association of South Africa (CANSA) and the 
University of Cape Town is developing such a tool for use in SSA. 
Preliminary results are expected in late 2018 and will greatly assist 
with development and evaluation of local interventions.
In SA, the first presentation to the public health system is to 
primary healthcare providers, who play a pivotal role in cancer triage, 
possible diagnosis and referral. Studies from SA have shown that 
some cancer patients had visited primary level healthcare facilities 
several times before referral.[23,30] Symptoms that could possibly be 
due to cancer are common, but most will not end up being cancer. [21] 
A concern in the study by Moodley et al.[30] was that women with 
comorbidities, who would have had greater contact with the primary 
healthcare services, had a longer diagnostic interval (time between 
first visit to a healthcare provider and time of diagnosis) compared 
with those without comorbidities.[30] Understanding primary 
healthcare providers’ knowledge of risk factors and symptoms as well 
as challenges faced in managing and referring patients with potential 
symptoms of breast symptoms could help identify potential targets 
for interventions to further reduce the diagnostic interval.
Various forms of support to primary healthcare providers exist 
internationally. Electronic risk assessment tools (RATs) are being 
evaluated in the UK,[34,35] and as SA develops electronic medical 
records and databases at multiple levels of the health system, it would 
be important to ensure that databases include variables relevant to the 
development of local RATs. Mobile technology support, educational/
training interventions and specialist outreach visits should also 
be explored and evaluated. Importantly, we also need to better 
understand the role of traditional healers in the pathways to cancer 
diagnosis and include them in awareness and other educational and 
training interventions.
Factors influencing the time from first primary healthcare provider 
visit to cancer diagnosis include referral and diagnostic services 
organisation; waiting times for appointments, tests and assay results; 
availability of pathology and laboratory services; and the financial 
impact on patients (e.g. time off work and transport costs).[21] The 
SA national breast cancer policy plan[10] is developing and expanding 
specialised breast units at regional level to have multidisciplinary 
capability for diagnosis and basic surgical management, and 
support from tertiary provincial oncology units. This support could 
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assist with rapid referral and decrease unnecessary delays. For 
timely diagnosis of symptomatic cervical cancer, establishing and 
expanding colposcopy services at secondary level will be important. 
Establishment of an electronic booking system could assist with 
appointments, referrals and feedback.
Achieving earlier diagnosis of symptomatic breast and cervical 
cancer is an important step in reducing the morbidity and mortality 
from these diseases. Potential improvements in timely diagnosis of 
breast and cervical cancer are possible with the implementation of 
evidence-based interventions, through a better-informed population 
and with a strengthened health system.
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